Client Work Detail

On May 22, 2008, Atrium Innovations Inc., a leading developer and marketer of science-based products for the health and nutrition industries, completed the sale of its Active Ingredients and Specialty Chemicals division, which offers in excess of 2,000 value-added products that include high-value proprietary active ingredients developed, acquired or in-licensed by it, to AXA Private Equity for total proceeds of US$166,400,000 in cash, subject to a post-closing working capital adjustment. Following the transaction, the main office of the Active Ingredients and Specialty Chemicals division will remain in Quebec City under the leadership of its existing management team.

Ogilvy Renault LLP, with a team that included Paul Raymond, Niko Veilleux, Steve Malas and Marie-Claude Mailloux (corporate/M&A) and Leanne Souquet (intellectual property), provided external counsel to Atrium.